+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Prenatal Testing Market - Forecasts from 2019 to 2024

  • PDF Icon


  • 106 Pages
  • October 2019
  • Region: Global
  • Knowledge Sourcing Intelligence LLP
  • ID: 4858237
Global prenatal testing market is projected to grow at a CAGR of 9.59% to reach US$6.191 billion by 2024, from US$3.574 billion in 2018. Prenatal tests are procedures that make sure that the mother and the fetus are healthy. Common prenatal testing includes ultrasound tests, amniocentesis, and chorionic villi sampling (CVS) tests. Growing healthcare expenditure, rising stress conditions due to the adoption of unhealthy living conditions are driving the growth of the global prenatal testing market in the forecast period. Currently, the focus is on non-invasive prenatal testing.

The market is fueled by the surge in the number of late pregnancies coupled with the rising demand of the non-invasive procedures for early diagnosis of chromosomal disorders to help in the proper management of disease during the initial period of the gestation. An increase in healthcare investments and growing awareness regarding prenatal testing will provide ample opportunities for growth for the market players during the given forecast period.

The Global Prenatal Testing Market - Forecasts from 2019 to 2024” is an exhaustive study that aims to present the key market trends through various chapters focusing on different aspects of the market. The study provides a detailed market overview through the market dynamics sections which detail key market, drivers, restraints, and opportunities in the current market. The report analyzes key opportunity regional markets, and the current technology penetration through lifecycle analysis. The report also analyzes the market through comprehensive market segmentation by techniques, indication, end-users, and geography.

Based on techniques, the market has been segmented as Non-invasive and Invasive. On the basis of indication, global prenatal testing market is segmented as genetic diseases and infectious diseases. Based on End-Users, the market has been segmented as Hospitals and Clinics and Diagnostic Labs.

Regional analysis has been provided with detailed analysis and forecast for the period 2019 to 2024. The global market has been broken down into North America, South America, Europe, Middle East and Africa, and Asia Pacific regions. The report also analyzes major countries across these regions with thorough analysis and forecast along with prevailing market trends and opportunities which each of these countries present for the manufacturers.

Major players in the prenatal testing market have been covered along with their relative competitive position and strategies. The report also mentions recent deals and investments of different market players over the last year. The company profiles section details the business overview, financial performance for the past three years, key products and services being offered along with the recent developments of these important players in prenatal testing market.


By techniques
  • Non-invasive
  • Sonography
  • Biochemical Screening Tests
  • Cell-Free DNA Screening Tests
  • Invasive
  • Amniocentesis
  • Chorionic Villus Sampling (CVS)

By Indication
  • Genetic Diseases
  • Infectious Diseases

By End Users
  • Hospitals and Clinics
  • Diagnostic Labs

By Geography

North America
  • USA
  • Canada
  • Mexico

South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • UK
  • Germany
  • Italy
  • Spain
  • Others

Middle East and Africa (MEA)
  • Israel
  • Saudi Arabia
  • Others

Asia Pacific (APAC)
  • China
  • Japan
  • India
  • Australia
  • Others

Table of Contents

1.1. Market Overview
1.2. Market Definition
1.3. Scope of the study
1.4. Currency
1.5. Assumptions
1.6. Base, and Forecast Years Timeline
2. Research methodology
2.1. Research Design
2.2. Secondary Sources
3. Executive Summary
4. Market Dynamics
4.1. Market Segmentation
4.2. Market Drivers
4.3. Market Restraints
4.4. Market Opportunities
4.5. Porter's Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Competitive Rivalry in the Industry
4.6. Life Cycle Analysis - Regional Snapshot
4.7. Market Attractiveness
5. Prenatal Testing Market by Technique
5.1. Non-invasive
5.1.1. Sonography
5.1.2. Biochemical Screening Tests
5.1.3. Cell-Free DNA Screening Tests
5.2. Invasive
5.2.1. Amniocentesis
5.2.2. Chorionic Villus Sampling (CVS)
6. Prenatal Testing Market by Indication
6.1. Genetic Diseases
6.2. Infectious Diseases
7. Prenatal Testing Market by End-Users
7.1. Hospitals and Clinics
7.2. Diagnostic Labs
8. Prenatal Testing Market by Geography
8.1. North America
8.1.1. USA
8.1.2. Canada
8.1.3. Mexico
8.2. South America
8.2.1. Brazil
8.2.2. Argentina
8.2.3. Others
8.3. Europe
8.3.1. UK
8.3.2. Germany
8.3.3. Italy
8.3.4. Spain
8.3.5. Others
8.4. Middle East and Africa
8.4.1. Israel
8.4.2. Saudi Arabia
8.4.3. Others
8.5. Asia Pacific
8.5.1. China
8.5.2. Japan
8.5.3. India
8.5.4. Australia
8.5.5. Others
9. Competitive intelligence
9.1. Competitive Benchmarking and Analysis
9.2. Strategies of Key Players
9.3. Recent Investments and Deals
10. Company Profile
10.1. Agilent Technologies, Inc.
10.2. Invitae Corporation
10.3. Illumina, Inc.
10.4. Laboratory Corporation of America® Holdings
10.5. Natera, Inc.
10.6. Quest Diagnostics Incorporated
10.7. F. Hoffmann-La Roche Ltd
10.8. Sequenom Laboratories
10.9. BGI Diagnosis Co., Ltd
10.10. IGENOMIX S.L.

Companies Mentioned

  • Agilent Technologies, Inc.
  • Invitae Corporation
  • Illumina, Inc.
  • Laboratory Corporation of America® Holdings
  • Natera, Inc.
  • Quest Diagnostics Incorporated
  • F. Hoffmann-La Roche Ltd
  • Sequenom Laboratories
  • BGI Diagnosis Co., Ltd